Novel linkages and navigation to improve childhood and adolescent cancer survivors' care transitions: a pilot randomized controlled trial across three health care systems

Active Grant Awarded Last action

Award ID
R01CA303339
Recipient
Awarding agency
Obligated
$2,818,902

Award facts

Assistance listing
93.393 Cancer Cause and Prevention Research
Completion date 5% complete
Place of performance
Dallas, TX 75390, USA

Award details come from USAspending.gov.

About this award

The National Cancer Institute, within the Department of Health and Human Services National Institutes of Health, awarded The University of Texas Southwestern Medical Center a grant of $2.818902 million on September 9, 2026, under Assistance Listing 93.393, Cancer Cause and Prevention Research, to fund Grant R01CA303339. The obligated amount is also $2.818902 million. The award funds a pilot randomized controlled trial, titled "Novel Linkages and Navigation to Improve Childhood and Adolescent Cancer Survivors' Care Transitions," across three health care systems. Under Aim 1, the recipient will use geospatial data and novel data linkages to examine how childhood cancer survivors treated at Children's Health used medical care over the past 30 years, identify risk factors for loss to follow-up, and update the survivor registry's address and contact information. Under Aim 2, it will identify adult survivors who attended a pediatric survivorship visit at Children's Health but had no known adult survivorship visit in the past three years, then conduct qualitative interviews on facilitators and barriers to care. Under Aim 3, it will pilot test a small randomized controlled trial to improve transitions from an established pediatric survivorship program to an adult onco-primary care clinic in either a safety net or academic health care system. Place of performance is Dallas, Texas 75390. The ultimate completion date is August 31, 2030. The source identifies no sub-recipients for this award.

Description

Abstract
Although childhood and adolescent cancer survivors (CCS) need lifelong, guideline-based survivorship care to manage heightened risks of secondary primary cancers and long-term effects from treatment, most CCS do not receive this as adults. As new adults balancing other life stressors, CCS have difficulty transitioning to adult survivorship care. Thus, successfully navigating the transition from pediatric to adult care demands collaboration between health systems, alongside dedicated support for both patients and clinical teams. Because the timing of transition, reasons for needing continued care, and life circumstances influence transition, a tailored approach that addresses the impact of non-medical drivers of health is vital for improving receipt of appropriate survivorship care. In aim 1, we will use geospatial data and novel data linkages to understand how CCS treated for their cancer at children's health used medical care as they aged over the past 30 years, identifying risk factors for loss to follow-up and updating our CCS registry with more accurate address and contact information. In aim 2, we will identify adult CCS who attended a pediatric survivorship visit at children's health, but who have not had a known adult survivorship visit in the past three years. We will conduct qualitative interviews with these unengaged CCS to help understand facilitators and barriers to care in each step of the transition pathway from childhood to adult survivorship care. Finally, the study aims to pilot test a small, randomized control trial aimed at improving transitions from an established pediatric survivorship program to an adult onco-primary care clinic (which provides primary and survivorship care) in either a safety net or academic health care system (aim 3). The pilot will test whether enhanced support and patient education from a nurse navigator will improve attendance of an adult survivorship clinic visit, compared to the standard referral pathway (usual care). The standard referral pathway uses usual clinical care, which includes an electronic referral to the adult onco-primary clinic. The enhanced pathway adds a nurse navigator who will provide education, assistance in transitioning to adult care, and logistic support during survivorship care. Primary outcome measures will focus on follow-up visits, while secondary outcomes will assess patients' perceived readiness for transitioning care. The goal of the pilot is to inform magnitude, variability, and acceptability for a fully powered trial to be completed later. Our strong multidisciplinary team and established pediatric and adult survivorship programs uniquely positions US to successfully pilot an intervention to improve CCS transitions to adult follow-up care. Additionally, we will improve understanding of the place and time CCS disconnect, thus identifying potential targets for intervention among CCS already lost to follow-up. Our findings will allow for a scale up to a full- scale trial to reduce disparities in transitions of care for all vulnerable CCS across all stages of transition

Transactions

Action Obligated Date
Amendment $186,335
Original award $2,632,567

Quick answers

Who received award R01CA303339?

R01CA303339 was awarded to The University Of Texas Southwestern Medical Center by National Cancer Institute (National Institutes of Health) on September 9, 2026.

How much is award R01CA303339 worth?

$2,818,902 has been obligated on R01CA303339.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award